Examples of Discontinued Compound in a sentence
MRE shall have the right of first refusal with respect to DTI's proposed grant to any bona fide third party of any right, title or interest of DTI in or to either any such composition, method or process or to any Non-Selected Compound or Discontinued Compound (a "Grant of DTI Rights").
At any time after the date of termination or expiration of this Agreement, either party may, upon written notice to the other party, proceed with Pre-Clinical Development and Development of a Discontinued Compound as an Independent Compound or an Independent Product, and such party shall be deemed to be the Independent Party therefor, as provided in Section 3.15.
In the event Licensee in its sole and absolute discretion elects to pursue the development of a CT Compound and subsequently discontinues the development of that CT Compound (the "Discontinued Compound"), Licensee shall notify Licensor thereof in writing.
If the other party indicates it is interested in participating in and committing resources to conduct Pre-Clinical Development of such Discontinued Compound, such Discontinued Compound shall be designated as a Designated Shared Compound as set forth in Section 3.2(a).
If the other party indicates it is interested in participating in and committing resources to conduct Pre-Clinical Development of such Discontinued Compound, such Discontinued Compound shall be designated as a Designated Shared Compound as set forth in Section 4A.2(a).
If the other party indicates it is not interested in participating in, and committing resources to, conduct Pre-Clinical Development of such Discontinued Compound, the initiating party, upon notice to the other party, may proceed with Pre-Clinical Development and Development of such Discontinued Compound as an Independent Compound or an Independent Product and the initiating party shall be deemed to be the Independent Party therefor, as provided in Section 4A.15.
At any time after [*], either party may, upon written notice to the other party, proceed with Pre-Clinical Development and Development of a Discontinued Compound as an Independent Compound or an Independent Product, and such party shall be deemed to be the Independent Party therefor, as provided in Section 4A.15.
Within 120 days of Licensor's receipt of such notification from Licensee, if Licensor desires to re-acquire the rights to the Discontinued Compound, Licensor shall so notify Licensee thereof in writing, setting forth the terms and conditions upon which it is desires to re-acquire such rights, and Licensor and Licensee shall thereafter negotiate such terms and conditions in good faith.
If a party provides such notice and the other party indicates it is not interested in participating in, and committing resources to, conduct Pre-Clinical Development of such Discontinued Compound, the initiating party, upon notice to the other party, may proceed with Pre-Clinical Development and Development of such Discontinued Compound as an Independent Compound or an Independent Product and the initiating party shall be deemed to be the Independent Party therefor, as provided in Section 3.15.
Immediately upon becoming a Discontinued Compound, the license rights granted by Impetis to Tarus in the applicable Impetis Compound shall revert to Impetis.